NFKB1 and intrahepatic cholangiocarcinoma: In intrahepatic cholangiocarcinoma (iCCA), ADAR1 enhances carcinogenic signals by mediating RNA editing of KPC1, which reduces the binding affinity of NF-κB1 p105 [395].